Abstract
The presence of increased amounts of the matrix component fibronectin together with alveolar macrophage-derived growth factor within the alveolar structures of patients with fibrotic lung disease may play a significant role in the fibrosis characteristic of these disorders, by amplifying the numbers of fibroblasts in the alveolar structures of these patients.
Original language | English (US) |
---|---|
Pages (from-to) | 96S |
Journal | CHEST |
Volume | 83 |
Issue number | 5 Suppl. |
DOIs | |
State | Published - 1983 |